Sorafenib tosylate
- Createtime： 2026-04-14
- Updatetime： 2026-04-15
Product Details
| useage |
Industrial use
|
| deliveryInfo |
|
| appearance |
powder
|
| Molecular Weight |
685.10
|
| aliasen |
|
| supplyCapacity |
50000MT/Month
|
| harbor |
Qingdao,China
|
| minorder |
1KG
|
| Appearance |
White to off-white powder
|
Shandong Huashang Chemical Co., Ltd. is a high-tech enterprise focused on industry of fine chemicals research and develop, produce and sale. Shandong Huashang Chemical Co., Ltd. is located in Shan Dong Ji Nan China. we have the ability to provide you high quality products. More than 90 % of our products are exported to developed countries and regions such as north America, Europe, Japan, South Korea and the Middle East.
Sorafenib tosylate
CAS: 475207-59-1
Molecular Formula: C28H24ClF3N4O7S2
Molecular Weight: 685.10
Alias: Sorafenib p-toluenesulfonate
Category: Antineoplastic API, tyrosine kinase inhibitor
Physical and Chemical Properties
- Appearance: White to off-white crystalline powder
- Melting Point: 220–224 °C
- Solubility: Slightly soluble in water, soluble in methanol, ethanol and DMSO
- Stability: Light and moisture sensitive
- Storage: Sealed, low temperature, dry and dark environment
Specification
| Item | Standard | Unit | Test Method |
| Appearance | White to off-white powder | - | Visual Inspection |
| Purity | ≥99.0 | % | HPLC |
| Moisture | ≤0.5 | % | KF Titration |
| Residue on Ignition | ≤0.1 | % | Gravimetric Method |
| Single Impurity | ≤0.1 | % | HPLC |
Main Application
Targeted anticancer drug, used for treatment of advanced renal cell carcinoma, hepatocellular carcinoma and differentiated thyroid carcinoma.
Note: Potent pharmaceutical raw material, strictly avoid random contact and ingestion.
